Latest Articles
October 3, 2018
Science In 60: Looking Beyond BRCA 1/2 to Identify Women at Risk for Breast Cancer
Science In 60: Looking Beyond BRCA 1/ 2 to Identify Women at Risk for Breast Cancer
BRCA1 & 2
Breast Cancer
Science in 60
Screening
September 19, 2018
Finding Answers Through Quality Exome Testing
Finding Answers Through Quality Exome Testing
Whole Exome Sequencing
September 4, 2018
3 Things You Need to Know about OvaNext
OvaNext is a comprehensive genetic test for hereditary ovarian cancer designed to give you accurate and clinically meaningful information to help you offer personalized treatment,…
Multigene Panel Testing
Ovarian Cancer
August 23, 2018
5 Things You Need to Know about Ambry’s Variant Review Process
Genetic testing laboratories should have a defined process to regularly review the evidence for genetic variants, so they can eventually come to a verdict and…
Variant of Unknown Significance
August 21, 2018
Science In 60: Tumor Characteristics Provide Evidence for Mismatch Repair Variant Pathogenicity
Tumor Characteristics Provide Evidence for Mismatch Repair Variant Pathogenicity By Shuwei Li, Sr. Statistical Geneticist I
Science in 60
VUS
August 10, 2018
Science in 60: Attacking a VUS from Multiple Angles
Ambry’s commitment is to find answers and clarify whether a variant is disease causing.
Science in 60
VUS
![overlay-bottom[1]](https://ambrygen.com/wp-content/uploads/2026/02/overlay-bottom1.svg)